Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis. Zettl UK, Schreiber H, Bauer-Steinhusen U, Glaser T, Hechenbichler K, Hecker M, BETAPATH Study Group Acta Neurol Scand. 2016 Oct 30. PMID: 27796033. Abstract CommentRecommendBookmarkWatch